• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

SASAKI Masato  佐々木 真人

ORCIDConnect your ORCID iD *help
… Alternative Names

佐々木 真人  ササキ マサト

Less
Researcher Number 80314483
Affiliation (based on the past Project Information) *help 2001 – 2004: 神戸大学, 大学院・医学系研究科, 助手
2000: 神戸大学, 医学部・附属病院, 助手
Review Section/Research Field
Principal Investigator
Cerebral neurosurgery
Except Principal Investigator
Cerebral neurosurgery / Cerebral neurosurgery
Keywords
Principal Investigator
VEGF / Anti-angiogenic Gene Therapy / Antisense / Malignant Gliomas / デコイ / HIF-1 / siRNA / RNA干渉 / ウイルス産生細胞 / 遺伝子治療 / 腫瘍血管新生 / 悪性グリオーマ / アンチセンス … More
Except Principal Investigator
… More 悪性グリオーマ / 遺伝子治療 / VEGF / 重粒子線 / gene therapy / angiogenesis / radiotherapy / brain tumor / 血管新生阻止療法 / 重粒子線治療 / 血管新生 / 放射線治療 / 脳腫瘍 / Caspase / IAP / Diablo / 治療耐性 / 分子標的治療 / Apoptosis / DIABO / Smac / 腫瘍血管新生 / アンチセンス / 炭素線 Less
  • Research Projects

    (4 results)
  • Research Products

    (1 results)
  • Co-Researchers

    (7 People)
  •  Smacペプチドを用いての悪性グリオーマに対する分子標的治療の研究

    • Principal Investigator
      KOHMURA Eiji
    • Project Period (FY)
      2003 – 2004
    • Research Category
      Grant-in-Aid for Exploratory Research
    • Research Field
      Cerebral neurosurgery
    • Research Institution
      Kobe University
  •  Basic research for the combination with anti-angiogenic therapy and heavy charged particle therapy against malignant gliomas

    • Principal Investigator
      EHARA Kazumasa
    • Project Period (FY)
      2003 – 2005
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Cerebral neurosurgery
    • Research Institution
      Kobe University
  •  重粒子線と血管新生阻止療法を併用した悪性神経膠腫の局所制御に関する基礎的研究

    • Principal Investigator
      EHARA Kazumasa
    • Project Period (FY)
      2001 – 2003
    • Research Category
      Grant-in-Aid for Scientific Research (B)
    • Research Field
      Cerebral neurosurgery
    • Research Institution
      Kobe University
  •  Antisense VEGF Tumor Gene Therapy for Malignant Gliomas (Anti-angiogenic Gene Therapy)Principal Investigator

    • Principal Investigator
      SASAKI Masato
    • Project Period (FY)
      2000 – 2002
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Cerebral neurosurgery
    • Research Institution
      Kobe University Graduate School of Medicine

All 2004

All Journal Article

  • [Journal Article] PTK787/ZK222548, an inhibitor of vascular endothelial growth factor receptor tyrosine kinases, decrease glioma growth and vasculalization2004

    • Author(s)
      Goldbrunner RH, Bendszus M, Wood J, Kiderlen M, Sasaki M, Tonn, JC
    • Journal Title

      Neurosurgery 55

      Pages: 426-426

    • Description
      「研究成果報告書概要(欧文)」より
    • Data Source
      KAKENHI-PROJECT-15591522
  • 1.  EHARA Kazumasa (20151996)
    # of Collaborated Projects: 3 results
    # of Collaborated Products: 0 results
  • 2.  HAYASHI Yoshitake (50189669)
    # of Collaborated Projects: 3 results
    # of Collaborated Products: 0 results
  • 3.  SUGIMURA Kazurou (00136384)
    # of Collaborated Projects: 2 results
    # of Collaborated Products: 0 results
  • 4.  KOHMURA Eiji (30225388)
    # of Collaborated Projects: 2 results
    # of Collaborated Products: 0 results
  • 5.  KAWAMURA Atsufumi (00346256)
    # of Collaborated Projects: 2 results
    # of Collaborated Products: 0 results
  • 6.  TAMAKI Norihiko (10030941)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 7.  SASAYAMA Takashi (10379399)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results

URL: 

Are you sure that you want to link your ORCID iD to your KAKEN Researcher profile?
* This action can be performed only by the researcher himself/herself who is listed on the KAKEN Researcher’s page. Are you sure that this KAKEN Researcher’s page is your page?

この研究者とORCID iDの連携を行いますか?
※ この処理は、研究者本人だけが実行できます。

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi